ASPI ASP ISOTOPES INC

ASP Isotopes Inc. to Host Investor Webcast on Tuesday, May 20, 2025 at 8:00 a.m. EST

ASP Isotopes Inc. to Host Investor Webcast on Tuesday, May 20, 2025 at 8:00 a.m. EST

WASHINGTON, May 19, 2025 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASP Isotopes” or the “Company”), an advanced materials company dedicated to the development of technology and processes for the production of isotopes for use in multiple industries, today announced that the Company will host an investor webcast starting at 8:00 a.m. EST on Tuesday, May 20, 2025.

The webcast can be accessed here:

An archived recording will be available on the “Investor Relations” section of the Company’s website at . The webcast will be archived and available for replay for at least 90 days after the event.

About ASP Isotopes Inc.

ASP Isotopes Inc. is a development stage advanced materials company dedicated to the development of technology and processes to produce isotopes for use in multiple industries. The Company employs proprietary technology, the Aerodynamic Separation Process (“ASP technology”). The Company’s initial focus is on producing and commercializing highly enriched isotopes for the healthcare and technology industries. The Company also plans to enrich isotopes for the nuclear energy sector using Quantum Enrichment technology that the Company is developing. The Company has isotope enrichment facilities in Pretoria, South Africa, dedicated to the enrichment of isotopes of elements with a low atomic mass (light isotopes).

There is a growing demand for isotopes such as Silicon-28 for enabling quantum computing; Molybdenum-100, Molybdenum-98, Zinc-68, Ytterbium-176, and Nickel-64 for new, emerging healthcare applications, as well as Chlorine-37, Lithium-6, Lithium-7 and Uranium-235 for green energy applications. The ASP Technology (Aerodynamic Separation Process) is ideal for enriching low and heavy atomic mass molecules. For more information, please visit .

Contacts

Jason Assad – Investor relations

Email: 

Telephone: 561-709-3043



EN
19/05/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on ASP ISOTOPES INC

 PRESS RELEASE

ASP Isotopes Inc. Announces Expected Commencement of Dual Listing on J...

ASP Isotopes Inc. Announces Expected Commencement of Dual Listing on Johannesburg Stock Exchange WASHINGTON, Aug. 08, 2025 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASP Isotopes” or the “Company”), an advanced materials company dedicated to the development of technology and processes for the production of isotopes for use in multiple industries, today provided an update on its application to list on the Johannesburg Stock Exchange (“JSE”). The JSE has approved the listing of the Company’s common stock on the Main Board of the JSE under the abbreviated name “ASPI”, share code “...

 PRESS RELEASE

ASP Isotopes Inc. and IsoBio, Inc. Announce Series Seed Funding of Iso...

ASP Isotopes Inc. and IsoBio, Inc. Announce Series Seed Funding of IsoBio, Inc. to Advance Innovative Antibody-Isotope Conjugates (AICsTM) For Cancer Treatment - IsoBio, Inc. (IsoBio) is a U.S.-based radiotherapeutic development company focused on developing a broad pipeline of mAb-based radioisotope therapeutics, known as antibody-isotope conjugates (AICsTM), targeting both derisked and novel tumor antigens for patients in need of new cancer therapies. - IsoBio has closed its initial Series Seed financing round, raising $5 million from ASP Isotopes Inc. (ASPI). - The strategic collaborat...

 PRESS RELEASE

Competition Commission of South Africa Approves the Offer by ASP Isoto...

Competition Commission of South Africa Approves the Offer by ASP Isotopes Inc. for Renergen Limited WASHINGTON, D.C., July 25, 2025 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASP Isotopes” or the “Company”), an advanced materials company dedicated to the development of technology and processes for the production of isotopes for use in multiple industries, today announced that the Company’s proposed offer to acquire all of the issued ordinary shares of JSE-listed Renergen Limited (“Renergen”) has been approved as of July 23, 2025, by the Competition Commission of South Africa, su...

 PRESS RELEASE

ASP Isotopes Inc. Announces Pricing of $60 Million Underwritten Regist...

ASP Isotopes Inc. Announces Pricing of $60 Million Underwritten Registered Direct Offering of Common Stock WASHINGTON, July 23, 2025 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASP Isotopes” or the “Company”), today announced the pricing of an underwritten registered direct offering of 7,500,000 shares of its common stock at a price of $8.00 per share to a single fundamental institutional investor. The gross proceeds from the offering, before deducting underwriting discounts and commissions and offering expenses, are expected to be approximately $60.0 million. The offering is exp...

 PRESS RELEASE

ASP Isotopes Inc. Announces Updates on the Progress of Commercial Prod...

ASP Isotopes Inc. Announces Updates on the Progress of Commercial Production at its Three Enrichment Facilities in South Africa WASHINGTON, July 17, 2025 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASP Isotopes” or the “Company”), an advanced materials company dedicated to the development of technology and processes for the production of isotopes for use in multiple industries, today announced several updates on the progress of commercial production at the Company’s three isotope enrichment facilities in Pretoria, South Africa as well as other corporate matters, in advance of a p...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch